Ryan Weispfenning has elected to take up the challenge of creating and leading the investor relations function at the planned ...

Weispfenning has more than 25 years of experience at Medtronic, joining its IR team 17 years ago. He led the function at the ...

Medtronic launches MiniMed 780G with Abbott sensor integration, expanding its diabetes ecosystem ahead of a planned spinoff.

Medtronic has announced that Ryan Weispfenning, vice president and head of investor relations, will join its diabetes business to establish and lead the investor relations function ...

The partnership is the first time Medtronic has integrated its insulin pumps with a sensor developed outside of the company.

Medtronic has announced the broad U.S. commercial launch of the MiniMed 780G insulin pump system integrated with the Instinct sensor, made by Abbott and designed exclusively for MiniMed systems.

Medtronic issues recall diabetes software affecting CareLink version 4.2B due to incorrect glucose data display, prompting clinician review.

Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced the broad U.S. commercial launch of the ...

Medtronic announced Wednesday that it will spin off its diabetes business into a standalone company. The medical device giant, which is domiciled in Dublin, Ireland but has its main office in Fridley, ...

In just the last few years, diabetes technology has grown exponentially smarter. Top of mind now for many devicemakers is the creation of a truly closed-loop system for insulin delivery—a system often ...

Is it too late to invest in the stock now that it's gained 23% this year? Let's find out whether Medtronic's shares are a buy heading into 2026. During the second quarter of its fiscal year 2026, ...